Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 1
1968 2
1969 2
1970 1
1971 1
1972 1
1973 1
1974 3
1975 3
1977 2
1978 6
1979 4
1980 3
1981 15
1982 9
1983 9
1984 5
1985 8
1986 1
2000 1
2002 1
2003 4
2004 4
2005 5
2006 3
2007 2
2008 5
2009 8
2010 9
2011 9
2012 9
2013 8
2014 2
2015 6
2016 6
2017 9
2018 19
2019 12
2020 6
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Results by year
Filters applied: . Clear all
Page 1
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT).
Utsunomiya K, Koshida R, Kakiuchi S, Senda M, Fujii S, Kurihara Y, Gunji R, Kaku K. Utsunomiya K, et al. Among authors: kakiuchi s. J Diabetes Investig. 2021 Feb;12(2):184-199. doi: 10.1111/jdi.13333. Epub 2020 Aug 25. J Diabetes Investig. 2021. PMID: 32597517 Free PMC article.
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real-world practice: Results of 12-month interim analysis of a long-term post-marketing surveillance study (J-STEP/LT).
Utsunomiya K, Senda M, Kakiuchi S, Kameda H, Tamura M, Kurihara Y, Gunji R, Fujii S, Kaku K. Utsunomiya K, et al. Among authors: kakiuchi s. J Diabetes Investig. 2020 Jan;11(1):132-141. doi: 10.1111/jdi.13097. Epub 2019 Jul 8. J Diabetes Investig. 2020. PMID: 31197929 Free PMC article.
Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real-world clinical practice: Results of 3-month interim analysis of a long-term post-marketing surveillance study (J-STEP/LT).
Utsunomiya K, Senda M, Kakiuchi S, Kameda H, Tamura M, Kurihara Y, Gunji R, Fujii S, Fujiwara H, Kaku K. Utsunomiya K, et al. Among authors: kakiuchi s. J Diabetes Investig. 2019 Sep;10(5):1272-1283. doi: 10.1111/jdi.13017. Epub 2019 Mar 6. J Diabetes Investig. 2019. PMID: 30702214 Free PMC article.
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24-month interim analysis of a long-term post-marketing study (J-STEP/LT).
Utsunomiya K, Kakiuchi S, Senda M, Fujii S, Kurihara Y, Gunji R, Koshida R, Kameda H, Tamura M, Kaku K. Utsunomiya K, et al. Among authors: kakiuchi s. J Diabetes Investig. 2020 Jul;11(4):906-916. doi: 10.1111/jdi.13233. Epub 2020 Mar 15. J Diabetes Investig. 2020. PMID: 32034997 Free PMC article.
Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
Kakiuchi S, Yakushijin K, Takagi I, Rikitake J, Akiyama H, Matsuba H, Hayashi Y, Kajimoto K, Iwata N. Kakiuchi S, et al. Front Med (Lausanne). 2020 Dec 23;7:625442. doi: 10.3389/fmed.2020.625442. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33425968 Free PMC article.
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page